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bances. Recently, a quantitative trait locus (QTL) inﬂuencing blood
pressure, left ventricular mass and heart interstitial ﬁbrosis was
genetically isolated within 788 kb on chromosome 8 segment of SHR-
PD5 congenic strain that contains only 7 genes, including mutant Plzf
(Promyelocytic leukemia zinc ﬁnger protein) gene.
METHODS To identify Plzf as a quantitative trait gene (QTG), we
targeted Plzf in the SHR using the TALEN technique and obtained
SHR line harboring mutant Plzf gene with a premature stop codon at
position of amino acid 58. The Plzfmutant allele is semi-lethal
since approximately 95% of newborn homozygous animals die peri-
natally due to a caudal regression syndrome. Heterozygous rats were
grossly normal and were used for metabolic and hemodynamic
analyses.
RESULTS SHR-Plzfþ/- versus SHR wild type controls exhibited reduced
body weight and relative weight of epididymal fat, lower serum tri-
glycerides and liver triglycerides, as well as lower serum cholesterol and
liver cholesterol. In addition, SHR-Plzfþ/- rats exhibited signiﬁcantly
increased sensitivity of adipose and muscle tissue to insulin action
when compared to wild type controls. The SHR-Plzfþ/- heterozygous
rats vs. wild type controls showed signiﬁcant amelioration of car-
diomyocyte hypertrophy and ﬁbrosis. Gene expression proﬁles revealed
differential expression of genes with the role in cell cycle.
CONCLUSIONS These results provide evidence for important role of
Plzf in regulation of metabolic and hemodynamic traits in the rat and
suggest cross-talk between cell cycle regulators, metabolism, cardiac
hypertrophy and ﬁbrosis.
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OBJECTIVES Digital medical treatment is a new medical model which
uses information technology through the entire medical process. In
this study, we combined clinical medicine and information technol-
ogy to create “Adult Common Diseases Computer Diagnostic System”
and evaluate its clinical diagnostic value on coronary artery disease,
gastroduodenal ulcers and hypertension portal.
METHODS First, we selected some symptoms and their relative
common diseases. Second, we edited diagnostic key points (cause,
exciting cause, clinical manifestation, past history, personal history
and family history) into choice questions according to textbooks,
guidelines and expertise, and stored them to the question database.
And we stored diagnostic results (preliminary diagnosis, sign of dis-
ease, auxiliary examination and clinical departments to visit) to the
answer database. Then we linked the two databases using metadata
base technology through special logic rules. After that, we evaluated
diagnostic value on coronary artery disease of the diagnostic system
(symptom: chest pain) in cardiovascular department and diagnostic
value on gastroduodenal ulcers as well as hypertension portal of the
diagnostic system (symptom: hematemesis) in digestive system
department.
RESULTS “Adult Common Diseases Computer Diagnostic System” con-
sists of four main interfaces. They are symptom selection interface (choose
one’s own symptoms), symptomatic question interface (answer ques-
tions), diagnostic results interface (review diagnostic results), and sign and
auxiliary examination interface (review sign and auxiliary examination).
1310 patients with chest pain in cardiovascular department were included.
Among the total, 1025 patients underwent coronary angiography (CAG).
Compared with results of CAG for diagnosis of coronary artery disease,
diagnostic value for system was a sensitivity of 85.1% and a speciﬁcity of
32.6%. Compared with clinical diagnosis, diagnostic value for system was
a sensitivity of 76.4% and a speciﬁcity of 46.3% for angina pectoris; and a
sensitivity of 58.1% and a speciﬁcity of 83.8% for myocardial infarction.
170 patients with hematemesis in digestive system department were
included, 127 among them underwent gastroscope. Compared with results
of gastroscope for diagnosis of gastroduodenal ulcer, diagnostic value for
system was a sensitivity of 50% and a speciﬁcity of 85.9%. Compared with
clinical diagnosis for portal hypertension, diagnostic value for system was
a sensitivity of 54.3% and a speciﬁcity of 90.8%.
CONCLUSIONS We succeed to create “Adult Common Diseases
Computer Diagnostic System”. In view of preliminary clinicalevaluation, the system had a good clinical diagnostic value for being
widely used.GW26-e0382
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OBJECTIVES Many undesirable effects may appear during interferon
alpha treatment for chronic hepatitis B. However, only a few cardio-
vascular adverse effects associated with interferon alpha have been
reported. This paper provides a rare case report regarding cardiac
toxicity of interferon alpha for chronic hepatitis B treatment.
METHODS After 4 months of pegylated interferon alpha-2a treatment,
a 38-year-old male patient with chronic viral hepatitis B developed
mild chest tightness and chest pain accompanied by nausea, vomit-
ing. Dynamic electrocardiogram showed paroxysmal tachycardia and
abnormal ST-T (T wave inversion).
RESULTS After withdrawal of interferon alpha, symptoms such as
chest tightness, chest pain and T wave inversion were gradually
relieved. The patient had no history of coronary heart disease before
medication, so myocardial ischemia due to interferon alpha-2a treat-
ment was considered.
CONCLUSIONS Although interferon-induced myocardial ischemia is
rare, it is still likely to develop into fatal danger, if not diagnosed and
treated timely. Prescribers should be alert to the possibility of this
severe adverse drug reaction associated with interferon use.GW26-e1591
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OBJECTIVES Hyperglycemia is a risk factor for cardiovascular
disease. However, the relationship between blood glucose variability
and cardiac structure and function remains unclear. The present
study aimed to explore the impact of glucose variability on cardiac
structure and function in patients with type 2 diabetes mellitus
(T2DM).
METHODS According to glucose variability, which was assessed by
mean amplitude of glycemic excursions (MAGE), 63 consecutive type
2 diabetic patients under glycemic control without any coronary
artery disease and hypertension were divided into two groups: sub-
jects with non-glucose ﬂuctuation (MAGE<3.9mmol/l, n¼31) and
subjects with glucose ﬂuctuation (MAGE3.9mmol/l, n¼32). Thirty
healthy controls (NC) were also enrolled. Myocardial structural and
functional changes were evaluated by echocardiography including
left ventricle end diastolic diameter (LVEDD), left ventricle end sys-
tolic diameter (LVESD), left ventricle end diastolic volume (LVEDV),
left ventricular end systolic volume (LVESV), interventricular septal
thickness (IVST), left ventricular posterior wall thickness (LVPW),
ejection fraction (EF), Mitral E wave, Mitral A wave, E/A ratio, and
Tei index.
RESULTS LVESD, LVESV, IVST, LVPW and LVEF had no signiﬁcant dif-
ferences among all groups (p<0.05). However, when compared to non-
glucose ﬂuctuation subjects and NC group, LVEDD (51.124.92mm vs.
46.144.65mm vs. 45.323.37mm, p<0.05) and LVEDV (101.324.93mm
vs. 87.836.19mm vs. 90.515.34mm, p<0.05) were signiﬁcant higher in
patients with glucose ﬂuctuation, while E/A ratio was signiﬁcant lower
(0.770.38 vs. 0.980.46 vs. 1.280.23, p<0.05). Furthermore, the Tei
index was higher in T2DM patients than that in NC group (0.490.1,
0.400.05, p<0.05, respectively), and was further increase in T2DM pa-
tients with glucose ﬂuctuation than that in patients with non-glucose
ﬂuctuation (0.520.01 vs 0.480.11, p<0.05).
CONCLUSIONS Blood glucose variability might impair myocardial per-
formances of T2DM patients, especially for diastolic function, which con-
tributes to the risk of cardiomyopathy among diabetic individuals.
